ArticleFrontiers in microbiology2017

A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association.

Huachao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.